首页> 外文期刊>Drug development and industrial pharmacy >Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model
【24h】

Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model

机译:在动物模型中开发用于吸入肺部药物的吸入室和干粉吸入器装置

获取原文
获取原文并翻译 | 示例
           

摘要

Context: Pulmonary route of administration is becoming more popular for drug delivery in pulmonary tract and lungs for local and systemic actions. Objective: A dry powder inhaler (DPI) for delivery of dry powder and a nose-only inhalation chamber for small animals that can be used with nebuliser/DPI were designed. Materials and methods: The inhalation chamber was made with a polypropylene-rectangular box and centrifuge tubes. DPI was made of a polypropylene tube. Micronized voriconazole and voriconazole solution were used for DPI and nebulizer, respectively, for both in vitro and in vivo studies. Results: In vitro drug deposition from nebulizer was found to be 1126% w/w and that from DPI was 42 to 57% w/w depending on experimental set up. Uniform deposition across all the inhalation ports was observed irrespective of the methods. Respirable fraction (RF) varied from 34 to 73% in case of nebulizer and from 47 to 54% in case of DPI. In vivo deposition of voriconazole in lungs was found to be 80130 g/g of lung tissue in case of DPI and 4068 g/g of lung tissue in case of using nebulizer. Discussion: DPI designed was efficient in fluidizing powder bed and dispensing dry powder for inhalation. The inhalation chamber designed was efficient in uniformly distributing drug in various inhalation ports of the chamber. Conclusions: The DPI and inhalation chamber designed can be successfully used for inhalation study with multiple animals especially mice.
机译:背景:在局部和全身作用的肺部和肺部给药中,肺部给药途径变得越来越普遍。目的:设计了一种用于递送干粉的干粉吸入器(DPI)和可与雾化器/ DPI一起使用的小动物鼻腔吸入腔。材料和方法:吸入室由聚丙烯矩形盒和离心管制成。 DPI由聚丙烯管制成。微粉化的伏立康唑和伏立康唑溶液分别用于DPI和雾化器,用于体外和体内研究。结果:根据实验设置,发现雾化器的体外药物沉积率为1126%w / w,DPI的体外药物沉积为42%至57%w / w。不论采用哪种方法,均观察到所有吸入口的沉积均匀。雾化器的可吸入分数(RF)从34%到73%,DPI则从47%到54%。在DPI情况下,伏立康唑在肺中的体内沉积量为80130 g / g,在使用雾化器的情况下为4068 g / g。讨论:设计的DPI在流化粉床和分配干粉进行吸入方面非常有效。设计的吸入室可有效地在各个吸入口中均匀地分配药物。结论:设计的DPI和吸入室可成功用于多种动物尤其是小鼠的吸入研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号